Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Radiodermatitis, also known as x-ray dermatitis, radiation dermatitis, radiation-induced skin reactions, or radiation injury, is a side effect of external beam ionizing radiation. Radiotherapy, used in the treatment of cancer or other diseases, is a major cause of radiodermatitis. The condition can also be a result of nuclear attacks and disasters.

The global radiodermatitis market is estimated to account for US$ 360.5 Mn in terms of value and is expected to reach US$ 472.8 Mn by the end of 2027.

Global Radiodermatitis Market: Drivers       

Increasing prevalence of cancer is expected to propel growth of the global radiodermatitis market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Moreover, R&D of new therapies for the treatment of radiodermatitis is also expected to aid in growth of the market. For instance, in December 2019, Kannalife, Inc. filed a new U.S. Patent for its proprietary and novel CBD-like molecules for the treatment of radiodermatitis and other skin disorders.

Topical agents held dominant position in the global radiodermatitis market in 2019, accounting for 70.5% share in terms of value, followed by dressing and oral medication, respectively

Figure 1. Global Radiodermatitis Market Share (%), by Value, by Product Type, 2019

Radiodermatitis  | Coherent Market Insights

Global Radiodermatitis Market: Restraints

Introduction of better radiation therapy equipment is expected to hinder growth of the global radiodermatitis market. The severity and likeliness to develop radiodermatitis can be either patient-related or treatment-related. The treatment-related factors include the type and quality of radiation beam and the location and size of the treatment field. Modern radiotherapy techniques, which include intensity-modulated radiation therapy (IMRT) and proton therapy, can diminish the risk for radiodermatitis by more accurately targeting tumor. Such scenario is expected to hinder growth of the market.

Moreover, high cost dressings such as honey-impregnated dressings and silicone dressings is also expected to limit growth of the market.

Global Radiodermatitis Market: Opportunities

R&D in radiodermatitis is expected to offer lucrative growth opportunities for players in the global radiodermatitis market. For instance, Jay Pharma is expected to begin a pilot study centered around radiodermatitis in the second half of 2020.

Moreover, investing in creating awareness regarding radiation-induced skin damage among caregivers and patients in regions with average standard care practices such as Asia Pacific, Latin America, and Middle East & Africa is also expected to aid in growth of the market.

The global radiodermatitis market was valued at US$ 346.9 Mn in 2019 and is forecast to reach a value of US$ 472.8 Mn by 2027 at a CAGR of 3.9% between 2020 and 2027.

Figure 2. Global Radiodermatitis Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

                 Radiodermatitis  | Coherent Market Insights

Market Trends/Key Takeaways

The prescription of topical products is high for the treatment of radiodermatitis. Despite insufficient evidence to support a particular product’s use, topical steroids and emollients are the most prescribed agents worldwide for the treatment of radiodermatitis. Aloe vera gel is used as an alternative herbal remedy. Gels can be useful in seborrhoeic areas, whereas creams can be used in areas outside skin folds and seborrhoeic areas.

Over-the-counter (OTC) products are more preferred than prescription products in the treatment of radiodermatitis. This can be attributed to word of mouth recommendations, easy availability of OTC products online as well as from local pharmacies. Hydrophilic creams sooth itching and redness and are available OTC.

Value Chain Analysis

The Value Chain for radiation dermatitis products begins from procurement of raw material, which would include API for oral medicine and silicone/hydrogel for silicone and hydrogel dressings. The material passes the stages of R&D, manufacturing, supply chain and finally is delivered to the end-users in clinics, hospitals or via retail stores (brick & mortar as well as online stores).

Global Radiodermatitis Market: Competitive Landscape

Major players operating in the global radiodermatitis market include, Acelity, Inc. (3M), BMG Pharma S.r.l., ConvaTec Group PLC, DermaSciences Inc. (Integra LifeSciences Holdings Corporation), Intermed Pharmaceuticals, Molnlycke Health Care, Smith & Nephew Plc, Stratpharma AG, Kannalife, Inc., and Jay Pharma

Global Radiodermatitis Market: Key Developments        

Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in October 2019, 3M acquired Acelity, Inc. and its KCI subsidiaries.

Similarly, in September 2019, Integra LifeSciences Holdings Corporation acquired Rebound Therapeutics, a developer of single-use medical devices that enable minimally invasive access in neurosurgery.

Radiodermatitis is a skin condition which involves skin becomes dry, itchy, and inflamed, which leads to redness, swelling, scaling, and crusting. Radiodermatitis is a body’s response to ionizing radiation, which is delivered in cancer patients and in imaging techniques. It is also known as x-ray dermatitis, radiation dermatitis, radiation-induced skin reactions, or radiation injury. The condition can also be a result of nuclear attacks and disasters.

Restraints of the Global Radiodermatitis Market

Major factors hampering the growth of the radiodermatitis market during the forecast period constitutes of introduction of technologically advanced radiation therapy techniques and instruments which reduce the risk of Radiodermatitis.

Key features of the study:

  • This report provides in-depth analysis of the global radiodermatitis market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global radiodermatitis market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Acelity, Inc. (3M), BMG Pharma S.r.l., ConvaTec Group PLC, DermaSciences Inc. (Integra LifeSciences Holdings Corporation), Intermed Pharmaceuticals, Molnlycke Health Care, Smith & Nephew Plc, Stratpharma AG, Kannalife, Inc., and Jay Pharma.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Radiodermatitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Radiodermatitis Market, By Product Type:
    • Topical Agents
      • Corticosteroids
      • Hydrophilic Creams
      • Others
    • Oral Medication
      • Corticosteroids
      • Other (Analgesic & Anti-Inflammatory)
    • Dressings
      • Hydrogel
      • Hydrocolloid
      • No Sting Barrier Film
      • Honey Impregnated Dressing
      • Silicone coated Dressing
      • Others
  • Global Radiodermatitis Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Radiodermatitis Market, By Geography:
    • North America
      • By Product Type
        • Topical Agents
          • Corticosteroids
          • Hydrophilic Creams
          • Others
        • Oral Medication
          • Corticosteroids
          • Other (Analgesic & Anti-Inflammatory)
        • Dressings
          • Hydrogel
          • Hydrocolloid
          • No Sting Barrier Film
          • Honey Impregnated Dressing
          • Silicone coated Dressing
          • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Product Type
        • Topical Agents
          • Corticosteroids
          • Hydrophilic Creams
          • Others
        • Oral Medication
          • Corticosteroids
          • Other (Analgesic & Anti-Inflammatory)
        • Dressings
          • Hydrogel
          • Hydrocolloid
          • No Sting Barrier Film
          • Honey Impregnated Dressing
          • Silicone coated Dressing
          • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type
        • Topical Agents
          • Corticosteroids
          • Hydrophilic Creams
          • Others
        • Oral Medication
          • Corticosteroids
          • Other (Analgesic & Anti-Inflammatory)
        • Dressings
          • Hydrogel
          • Hydrocolloid
          • No Sting Barrier Film
          • Honey Impregnated Dressing
          • Silicone coated Dressing
          • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Product Type
        • Topical Agents
          • Corticosteroids
          • Hydrophilic Creams
          • Others
        • Oral Medication
          • Corticosteroids
          • Other (Analgesic & Anti-Inflammatory)
        • Dressings
          • Hydrogel
          • Hydrocolloid
          • No Sting Barrier Film
          • Honey Impregnated Dressing
          • Silicone coated Dressing
          • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Product Type
        • Topical Agents
          • Corticosteroids
          • Hydrophilic Creams
          • Others
        • Oral Medication
          • Corticosteroids
          • Other (Analgesic & Anti-Inflammatory)
        • Dressings
          • Hydrogel
          • Hydrocolloid
          • No Sting Barrier Film
          • Honey Impregnated Dressing
          • Silicone coated Dressing
          • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type
        • Topical Agents
          • Corticosteroids
          • Hydrophilic Creams
          • Others
        • Oral Medication
          • Corticosteroids
          • Other (Analgesic & Anti-Inflammatory)
        • Dressings
          • Hydrogel
          • Hydrocolloid
          • No Sting Barrier Film
          • Honey Impregnated Dressing
          • Silicone coated Dressing
          • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Acelity, Inc. (3M)*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • BMG Pharma S.r.l.
    • ConvaTec Group PLC
    • DermaSciences Inc. (Integra LifeSciences Holdings Corporation)
    • Intermed Pharmaceuticals
    • Mölnlycke Health Care
    • Smith & Nephew Plc
    • Stratpharma AG
    • Kannalife, Inc.
    • McKesson Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario
  4. Global Radiodermatitis Market, By Product Type, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Topical Agents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
        • Corticosteroids
        • Hydrophilic Creams
        • Others
    • Oral Medication
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
        • Corticosteroids
        • Other (Analgesic & Anti-Inflammatory)
    • Dressings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
        • Hydrogel
        • Hydrocolloid
        • No Sting Barrier Film
        • Honey Impregnated Dressing
        • Silicone coated Dressing
        • Others
  5. Global Radiodermatitis Market, By Distribution Channel, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
  6. Global Radiodermatitis Market, By Regions, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Acelity, Inc. (3M)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • BMG Pharma S.r.l.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • ConvaTec Group PLC
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • DermaSciences Inc. (Integra LifeSciences Holdings Corporation)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Intermed Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Mölnlycke Health Care
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Smith & Nephew Plc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Stratpharma AG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Kannalife, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • McKesson Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 26 figures on “Radiodermatitis Market – Global forecast to 2027.

Frequently Asked Questions

The global radiodermatitis market was valued at US$ 346.9 Mn in 2019 and is forecast to reach a value of US$ 472.8 Mn by 2027 at a CAGR of 3.9% between 2020 and 2027.
Major factor driving the growth of global radiodermatitis market during the forecast period increasing prevalence of cancer, and product launches and approvals for Radiodermatitis treatment.
Major factors hampering the growth of the radiodermatitis market during the forecast period constitutes of introduction of technologically advanced radiation therapy techniques and instruments which reduce the risk of Radiodermatitis.
Topical agents held dominant position in the global radiodermatitis market in 2019.
North America radiodermatitis market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Acelity, Inc. (3M), BMG Pharma S.r.l., ConvaTec Group PLC, DermaSciences Inc. (Integra LifeSciences Holdings Corporation), Intermed Pharmaceuticals, Molnlycke Health Care, Smith & Nephew Plc, Stratpharma AG, Kannalife, Inc., and Jay Pharma
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner